mesowatch
Mary Pieper

Mary Pieper - author

Mary Pieper is a seasoned journalist, focusing on asbestos awareness and legal and medical issues. She earned her Bachelor's in English with a minor in Journalism from the University of Northern Iowa. Mary's extensive experience includes nearly 20 years as a reporter at the Globe Gazette in Mason City, Iowa, demonstrating her commitment to impactful journalism.

PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma

PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma

Mary Pieper

5 mins read - August 15, 2024

What if a technology could look inside the human body not just to see what our organs looked like, but to track their processes as they function? For patients of the rare, aggress...

Research Supports DHA Treatment as Effective for Pleural Mesothelioma Patients

Research Supports DHA Treatment as Effective for Pleural Mesothelioma Patients

Mary Pieper

2 mins read - August 12, 2024

A recent study provides preclinical evidence that treating pleural mesothelioma with a DNA hypomethylating agent (DHA) is an effective form of therapy.  Recently, the co-target...

J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits

J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits

Mary Pieper

2 mins read - August 12, 2024

Bloomberg reported Monday that more than 75% of the plaintiffs who filed lawsuits against Johnson & Johnson claiming that the use of asbestos-contaminated talc products resulted i...

Jury Trial Underway in Case of Man Who Blames J&J Baby Powder For His Mesothelioma

Jury Trial Underway in Case of Man Who Blames J&J Baby Powder For His Mesothelioma

Mary Pieper

4 mins read - August 12, 2024

A jury trial began in South Carolina this week to determine if a man’s use of asbestos-contaminated Johnson & Johnson’s baby powder was the cause of his mesothelioma.  Michael ...

Rising Mesothelioma Cases in Senior Women: Two Decades of Concern

Rising Mesothelioma Cases in Senior Women: Two Decades of Concern

Mary Pieper

5 mins read - August 5, 2024

According to an analysis performed by Mesowatch, the number of senior women in the United States dying from mesothelioma — a fatal form of cancer caused by exposure to deadly asbe...

Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit

Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit

Mary Pieper

2 mins read - July 29, 2024

A jury ordered Avon Products, Inc. to pay $24.4 million Friday to the family of a man who developed cancer decades after being exposed to asbestos-contaminated talc while working ...

Lawmakers Aim to Halt J&J’s Texas Two-Step Tactics

Lawmakers Aim to Halt J&J’s Texas Two-Step Tactics

Mary Pieper

3 mins read - July 25, 2024

A bipartisan group of lawmakers proposed legislation on Capitol Hill Tuesday to end the “Texas Two-Step,” a bankruptcy maneuver that Johnson & Johnson and Georgia Pacific have bee...

J&J Proposes $505 Million Settlement With Talc Suppliers

J&J Proposes $505 Million Settlement With Talc Suppliers

Mary Pieper

2 mins read - July 17, 2024

Johnson & Johnson has proposed a $505 million settlement with two bankrupt mining companies that supplied J&J with asbestos-contaminated talc for its talcum powder products.  P...

$8M Verdict Against Railway That Spilled Asbestos Material Upheld

$8M Verdict Against Railway That Spilled Asbestos Material Upheld

Mary Pieper

3 mins read - July 15, 2024

A federal court upheld an $8 million verdict Thursday against BNSF Railway over the deaths of two former residents of Libby, Montana, where asbestos-containing mining material was...

WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns

WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns

Mary Pieper

3 mins read - July 8, 2024

The World Health Organization on Friday stated talc is “probably carcinogenic,” based on a study by the WHO’s International Agency for Research on Cancer (IARC).The study, publishe...

Promising Immunotherapy Case for Peritoneal Mesothelioma

Promising Immunotherapy Case for Peritoneal Mesothelioma

Mary Pieper

3 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant ...

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Mary Pieper

4 mins read - July 2, 2024

A scientist has scored a victory over Johnson & Johnson, which alleged her influential research linking asbestos-contaminated cosmetic products to the deadly cancer mesothelioma wa...

mesowatch

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy Policy

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
The content on this website is protected by law and provided for informational purposes only. It is not intended as a substitute for professional medical or legal advice. Always seek advice from qualified professionals for health or legal matters.Disclaimer